Effect of Hepatic Impairment on Eluxadoline Pharmacokinetics

Por Marbury, Thomas C., Berg, Jolene Kay, Dove, Leonard S., Covington, Paul S.
Publicado no J Clin Pharmacol (2017)

Evaluating the fitness of human lysozyme transgenic dairy goats: growth and reproductive traits

Por Jackson, Kathryn A., Berg, Jolene M., Murray, James D., Maga, Elizabeth A.
Publicado em 2010

Pharmacokinetics of nalbuphine hydrochloride extended release tablets in hemodialysis patients with exploratory effect on pruritus

Por Hawi, Amale, Alcorn, Harry, Berg, Jolene, Hines, Carey, Hait, Howard, Sciascia, Thomas
Publicado no BMC Nephrol (2015)

A randomized, double-blind, placebo-controlled, multiple-dose, parallel-group clinical trial to assess the effects of teduglutide on gastric emptying of liquids in healthy subjects

Por Berg, Jolene Kay, Kim, Eric H, Li, Benjamin, Joelsson, Bo, Youssef, Nader N
Publicado em 2014

Pharmacokinetics and pharmacodynamics of ticagrelor in subjects on hemodialysis and subjects with normal renal function

Por Teng, Renli, Muldowney, Sharen, Zhao, Yonggang, Berg, Jolene Kay, Lu, Jonathan, Khan, Naeem D.
Publicado no Eur J Clin Pharmacol (2018)

Cefiderocol, a Siderophore Cephalosporin for Gram‐Negative Bacterial Infections: Pharmacokinetics and Safety in Subjects With Renal Impairment

Por Katsube, Takayuki, Echols, Roger, Arjona Ferreira, Juan Camilo, Krenz, Heidi K., Berg, Jolene Kay, Galloway, Christopher
Publicado no J Clin Pharmacol (2016)

Pharmacokinetics and Safety of Omadacycline in Subjects with Impaired Renal Function

Por Berg, Jolene K., Tzanis, Evan, Garrity-Ryan, Lynne, Bai, Stephen, Chitra, Surya, Manley, Amy, Villano, Stephen
Publicado no Antimicrob Agents Chemother (2018)

Phase I trial to investigate the effect of renal impairment on isavuconazole pharmacokinetics

Por Townsend, Robert W., Akhtar, Shahzad, Alcorn, Harry, Berg, Jolene K., Kowalski, Donna L., Mujais, Salim, Desai, Amit V.
Publicado no Eur J Clin Pharmacol (2017)

Double-Blind, Randomized Study Evaluating the Glycemic and Anti-inflammatory Effects of Subcutaneous LY2189102, a Neutralizing IL-1β Antibody, in Patients With Type 2 Diabetes

Por Sloan-Lancaster, Joanne, Abu-Raddad, Eyas, Polzer, John, Miller, Jeffrey W., Scherer, Joel C., De Gaetano, Andrea, Berg, Jolene K., Landschulz, William H.
Publicado em 2013

Effect of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Verinurad, a Selective Uric Acid Reabsorption Inhibitor

Por Smith, William B., Hall, Jesse, Berg, Jolene K., Kazimir, Michal, Yamamoto, Amy, Walker, Susan, Lee, Caroline A., Shen, Zancong, Wilson, David M., Zhou, Dongmei, Gillen, Michael, Marbury, Thomas C.
Publicado no Clin Drug Investig (2018)

Effect of Rifampin, a Potent Inducer of Drug-Metabolizing Enzymes, on the Pharmacokinetics of Raltegravir

Por Wenning, Larissa A., Hanley, William D., Brainard, Diana M., Petry, Amelia S., Ghosh, Kalyan, Jin, Bo, Mangin, Eric, Marbury, Thomas C., Berg, Jolene K., Chodakewitz, Jeffrey A., Stone, Julie A., Gottesdiener, Keith M., Wagner, John A., Iwamoto, Marian
Publicado em 2009